logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Akihiro Tamiya

nho kinki chuo chest medical center
H指数:29
被引数:2,838

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of preexisting interstitial lung disease on pneumonitis and survival during first-line immune checkpoint inhibitor-based therapy in non-small cell lung cancer

非小细胞肺癌患者接受一线免疫检查点抑制剂治疗期间，预存间质性肺病对肺炎及生存的影响

European Journal of Cancer
IF7.1
2026-06-210
OA
Kinnosuke Matsumoto; Yuji Yamamoto; Takayuki Shiroyama; Tomoki Kuge; Akito Miyazaki; Kiyohide Komuta; Motohiro Tamiya; Kazumi Nishino; Akihiro Tsukaguchi; Akihiro Tamiya; Yasuhiro Mihashi; Junji Uchida; Masahide Mori; Keijiro Yamauchi; Hidekazu Suzuki; Yuhei Kinehara; Koki Moritomo; Nao Shoshihara; Hirotomo Machiyama; Kensuke Kanaoka
Impact of Sequential Ramucirumab Plus Docetaxel After PD-1 Inhibitors on Anti-PD-1 Antibody-Bound T-Cell Dynamics and Clinical Outcomes

序贯拉姆昔利珠单抗联合多西他赛在PD-1抑制剂后的抗PD-1抗体结合T细胞动力学及临床结局的影响

Cancer Science
IF4.3
2026-01-300
OAAI
Kinnosuke Matsumoto; Yujiro Naito; Takayuki Shiroyama; Motohiro Tamiya; Kazumi Nishino; Akihiro Tamiya; Kyoichi Okishio; Yuhei Kinehara; Tomoki Kuge; Masahide Mori; Shingo Satoh; Hidekazu Suzuki; Satoshi Tetsumoto; Toshie Niki; Yasuhiko Suga; Akio Osa; Toshiyuki Minami; Shohei Koyama; Yoshito Takeda; Nobuyuki Takakura; Atsushi Kumanogoh
Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study

晚期非小细胞肺癌患者中，一线使用pembrolizumab与pembrolizumab联合化疗的长期生存比较：一项多中心倾向性匹配队列研究

Lung Cancer
IF4.4
2025-11-070
OAAI
Nao Shoshihara; Kinnosuke Matsumoto; Takayuki Shiroyama; Kiyohide Komuta; Akito Miyazaki; Motohiro Tamiya; Akihiro Tsukaguchi; Akihiro Tamiya; Tomoki Kuge; Yasuhiro Mihashi; Masahide Mori; Keijiro Yamauchi; Hidekazu Suzuki; Yuhei Kinehara; Hirotomo Machiyama; Satoshi Tanaka; Toshie Niki; Soichiro Kato; Yuki Nishikawa; Akio Osa; Kouji Azuma; Yoshito Takeda; Atsushi Kumanogoh
Corrigendum to “Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study” [Eur J Cancer. 2025;228:115748]

勘误：“Timing of first pembrolizumab infusion and long-term outcomes in non-small cell lung cancer: A retrospective multicenter study” [Eur J Cancer. 2025;228:115748]

European Journal of Cancer
IF7.1
2025-10-020
PRE
Akihiro Tsukaguchi; Kinnosuke Matsumoto; Akihiro Tamiya; Motohiro Tamiya; Masahide Mori; Hidekazu Suzuki; Takayuki Shiroyama; Akito Miyazaki; Kiyohide Komuta; Yasuhiro Mihashi; Keijiro Yamauchi; Kensuke Kanaoka; Tomoki Kuge; Yuhei Kinehara; Koji Azuma; Toshie Niki; Koki Moritomo; Yoshito Takeda; Atsushi Kumanogoh
Timing of First Pembrolizumab Infusion and Long-Term Outcomes in Non-Small Cell Lung Cancer: A Retrospective Multicenter Study

首次帕博利珠单抗输注的时间与非小细胞肺癌的长期结局：一项回顾性多中心研究

European Journal of Cancer
IF7.1
2025-08-300
PRE
Akihiro Tsukaguchi; Kinnosuke Matsumoto; Akihiro Tamiya; Motohiro Tamiya; Masahide Mori; Hidekazu Suzuki; Takayuki Shiroyama; Akito Miyazaki; Kiyohide Komuta; Yasuhiro Mihashi; Keijiro Yamauchi; Kensuke Kanaoka; Tomoki Kuge; Yuhei Kinehara; Koji Azuma; Toshie Niki; Koki Moritomo; Yoshito Takeda; Atsushi Kumanogoh
Circulating Tumour DNA in Patients With EGFR-Mutated Non-Small-Cell Lung Cancer and Early Disease Progression After First-Line Osimertinib Treatment: The ELUCIDATOR Multicentre Prospective Observational Study

携带EGFR突变非小细胞肺癌患者经第一线奥希替尼治疗后早期疾病进展的循环肿瘤DNA：ELUCIDATOR多中心前瞻性观察研究

CANCER MEDICINE
IF3.1
2025-04-050
OAAI
Tamiya, Akihiro; Mizumori, Yasuyuki; Osuga, Mitsuo; Isa, Shun-ichi; Taniguchi, Yoshihiko; Nakamura, Keiichi; Harada, Daijiro; Shinohara, Tsutomu; Yanai, Hidetoshi; Nakatomi, Katsumi; Oki, Masahide; Mori, Masahide; Kuwako, Tomohito; Yamazaki, Koji; Tamura, Atsuhisa; Ando, Masahiko; Koh, Yasuhiro
Updated results of a prospective observational multicenter study on resistance mechanisms to osimertinib using circulating tumor DNA analyses in EGFR-mutated non- small cell lung cancer patients (ELUCIDATOR study)
CANCER RESEARCH
IF16.6
2024-03-220
PRE
Osuga, Mitsuo; Tamiya, Akihiro; Harada, Daijiro; Mizumori, Yasuyuki; Isa, Shun-ichi; Taniguchi, Yoshihiko; Nakamura, Keiichi; Shinohara, Tsutomu; Yanai, Hidetoshi; Nakatomi, Katsumi; Oki, Masahide; Mori, Masahide; Kuwako, Tomohito; Yamazaki, Koji; Tamura, Atsuhisa; Ando, Masahiko; Koh, Yasuhiro
A Retrospective, Multicenter, Observational Study to Evaluate Clinical Outcomes of Lorlatinib After Alectinib in Patients With ALK-Positive NSCLC in Japan
JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-05-012
OA
Goto, Yasushi; Kenmotsu, Hirotsugu; Tamiya, Motohiro; Murakami, Shuji; Kurata, Takayasu; Yanagitani, Noriko; Taniguchi, Hirokazu; Kuyama, Shoichi; Shimizu, Junichi; Yokoyama, Toshihide; Shimada, Naoko; Maeda, Tadashi; Tamiya, Akihiro; Uchiyama, Ayumi; Imaizumi, Kazuyoshi; Takahama, Takayuki; Kato, Terufumi; Hayashi, Hidetoshi; Shiraiwa, Naoko; Toyoizumi, Shigeyuki; Kikkawa, Hironori; Thomaidou, Despina; Nishio, Makoto
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
SCIENTIFIC REPORTS
IF3.9
2023-03-063
OAAI
Fujimoto, Daichi; Miura, Satoru; Tomii, Keisuke; Sumikawa, Hiromitsu; Yoshimura, Kenichi; Wakuda, Kazushige; Oya, Yuko; Yokoyama, Toshihide; Kijima, Takashi; Asao, Tetsuhiko; Tamiya, Motohiro; Nakamura, Atsushi; Yoshioka, Hiroshige; Tokito, Takaaki; Murakami, Shuji; Tamiya, Akihiro; Yokouchi, Hiroshi; Watanabe, Satoshi; Yamaguchi, Ou; Morinaga, Ryotaro; Jodai, Takayuki; Ito, Kentaro; Shiraishi, Yoshimasa; Kogure, Yoshihito; Shibaki, Ryota; Yamamoto, Nobuyuki

研究方向

暂未获取到该数据
M
Motohiro Tamiya
H 指数:32论文数:372被引数:3,527
Y
Yoshihiko Taniguchi
H 指数:24论文数:163被引数:1,949
S
Shinji Atagi
H 指数:43论文数:297被引数:7,742
M
Masaki Kanazu
H 指数:19论文数:71被引数:1,081
T
Takayuki Shiroyama
H 指数:25论文数:244被引数:3,661
T
Tomoya Kawaguchi
H 指数:46论文数:438被引数:1.0万
H
Hidekazu Suzuki
H 指数:58论文数:557被引数:1.2万
K
Kyoichi Okishio
H 指数:23论文数:196被引数:1,592
Y
Yasuhiro Koh
H 指数:38论文数:284被引数:4,845
T
Tomonori Hirashima
H 指数:40论文数:249被引数:1.2万